SIFCO Stock Surges Nearly 310% YTD: What's Behind the Rally?
SIF's strong defense demand, growing aerospace backlog and operational improvements support growth prospects despite profitability and supply-chain challenges.
Zacks
SIFCO Stock Surges Nearly 310% YTD: What's Behind the Rally?
SIF's strong defense demand, growing aerospace backlog and operational improvements support growth prospects despite profitability and supply-chain challenges.
Zacks
More News
The Zacks Analyst Blog Highlights Space Exploration, Dell, KLA, AXIL Brands and Optex
Space Exploration, Dell, KLA, AXIL Brands and Optex are included in this Analyst Blog.
Zacks
OPXS Falls 24% in Three Months: Should You Buy the Dip or Wait?
Optex Systems faces weaker periscope demand, a shrinking backlog and rising costs as defense-program changes pressure revenue visibility and margins.
Zacks
SIFCO Stock Gains Nearly 50% in the Past Six Months: Time to Buy?
SIF's strong demand, backlog visibility, operational gains and lower debt are fueling investor optimism despite labor and supply-chain challenges.
Zacks
The Zacks Analyst Blog Highlights Apple, KLA, Western Digital and Optex Systems
AI demand and cloud spending support KLA and Western Digital, while Apple and Optex face mixed headwinds and opportunities in Zacks' latest research.
Zacks
SIFCO Stock Gains 64% in the Past 3 Months: What's Behind the Rally?
SIF's improving profitability, strong demand, backlog growth and operational gains are fueling investor optimism despite labor and supply-chain challenges.
Zacks
OPXS' Q2 Earnings Down Y/Y Amid Delayed Contract Awards
Optex Systems posts year-over-year declines in fiscal Q2 earnings per share and revenues due to delayed government contract awards, though gross margins improve through pricing gains and operational efficiencies.
Zacks
The Zacks Analyst Blog UnitedHealth, Merck & Co., Qualcomm, EVI and Optex
UNH, MRK and QCOM drew focus as analysts highlighted growth drivers, pipeline strength and expanding AI and automotive opportunities.
Zacks
Top Research Reports for UnitedHealth, Merck & Qualcomm
UnitedHealth, Merck and QUALCOMM lead Zacks' top research picks as analysts highlight growth drivers, earnings trends and key risks.
Zacks
Optex Systems (NASDAQ:OPXS) Raised to Strong-Buy at Freedom Capital
Freedom Capital upgraded Optex Systems to a "strong-buy" rating in a report on Monday...